Malignant Nervous System Neoplasm — Trials

Malignant Nervous System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,457 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 953
Recruiting: 528
Ph III recruiting: 35
Growth YoY: +15%
Industry share: 15%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.9%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (495)

clinicaltrialsPublishedShowing 151–200 of 1,375 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04743661	131I-Omburtamab, in Recurrent Medulloblastoma and Ependymoma	active not recruiting	Phase 2	62	Pediatric Brain Tumor ConsortiumNETWORK	1	Jul 28, 2026	clinicaltrials
NCT06057948	A Study of a Vaccine in Combination With Beta-glucan in People With Neuroblastoma	recruiting	Phase 2	94	Memorial Sloan Kettering Cancer CenterOTHER	1	Jul 28, 2026	clinicaltrials